eBook: The role of RWE in regulatory approvals. Download here.

The biggest innovation you can make is a better decision.

Aetion Evidence Platform® delivers real-world evidence for life sciences companies, payers, and at-risk providers. We help you answer the high-stakes questions in health care: what works best, for whom, and when. Because better answers lead to better decisions.

Learn more

ICER to use Aetion observational RWE to update value assessment of treatments for hereditary angioedema

ICER and Aetion will work together to generate RWE to inform value reassessments for three hereditary angioedema treatments, a continuation of our existing collaboration to advance the use of RWE in HTA.

Learn more
Image for logos

Real-Time Insights & Evidence

The first and only real-time real-world evidence system.

Learn more

4th Annual MarketsandMarkets RWD, Life Sciences Analytics, and Market Access Virtual Conference

On Thursday, April 22, join Dr. Nirosha Lederer as she discusses using RWE to demonstrate drug effectiveness at the 4th Annual MarketsandMarkets Real-World Data, Life Sciences Analytics, and Market Access Virtual Conference.

Learn more

The Evidence Hub

Want to learn more about real-world evidence? Read up on perspectives, milestones, and best practices in real-world evidence and value-based health care on our blog, the Evidence Hub.

Read more

Population Level Analytics for COVID-19

Powered by Roche, this tool allows users to compare county-level COVID-19 real-world data across the U.S.

Learn more

Powered by Roche, this tool allows users to compare county-level COVID-19 real-world data across the U.S.

Learn more
Image for

Scientific rigor for real-world evidence solutions

As a partner to the majority of the top 20 global biopharma firms, leading payers, and the FDA, Aetion informs the most critical decisions in the industry. Our transparent analyses guide product development, commercialization, and payment innovation into health care’s modern era.

Image for real-world evidence solutions

Rapid answers for decisions that matter

Aetion Evidence Platform moves the application of real-world evidence from descriptive analytics to causal conclusions. And it delivers answers within days and weeks—the rapid results needed to improve clinical and financial outcomes. Turn your best available information into insights you can use now.

Image for real-world evidence platform

Trusted real -world evidence for all stakeholders

Our solutions begin with asking the right question and determining the right data from our commercial and academic partners around the world. Then, the analytic workflows of the platform—meeting and setting international scientific standards—enable you to validate assumptions and align stakeholders. Including on value-based care imperatives such as outcomes-based contracting.

Image for real-world-evidence

Aetion Evidence Platform has been tremendous for us with regards to delivering RWE more efficiently. From an operational perspective, it has helped us generate high quality evidence faster, and allows us to deliver more for our stakeholders.

— Dr. Robert LoCasale
Head of Real World Evidence, Sanofi

The most intriguing part of the Aetion story is the ability to have a very consistent analytic approach that can be applied across multiple data sets.

— Dr. Amy Abernethy (in STAT)
Principal Deputy Commissioner, FDA

Aetion’s rapid turn-around time is critical, as is the fact that their analyses are based on our membership. By using predictive modeling to identify high-risk patients—who will become high-cost—we’re able to quickly engage with providers and health systems to intervene early. This improves outcomes for our highest-risk patient populations.

— Dr. Saira Jan
Director of Pharmacy Strategy and Clinical Integration, Horizon Blue Cross Blue Shield of New Jersey

As part of our digital business transformation, we believe that strategic partnerships will advance our capabilities for rapid analytics. The Aetion Evidence Platform has helped reduce the completion time for UCB’s RWE initiatives by 50%, and has enhanced our capabilities to run multiple concurrent studies.

— Dr. Eddie Lee
Head, US HEOR Strategy, UCB

The Evidence Digest

Subscribe to our newsletter for insights and updates on research and applications for real-world evidence in life sciences and value-based health care.

eBook

The role of real-world evidence in FDA approvals

View now
arrowcalendarchevronclosecollapsecountdownfacebookflickrinstagramlinelinkedinlocationpinsearchsocialtwitteryoutube